Business
COVID-19 vaccine from China’s Sinovac 91.25 per cent effective, Turkey says after trial involving 7,000 volunteers – ABC News
A COVID-19 vaccine developed by China’s Sinovac Biotech is 91.25 per cent effective, according to interim data from a late-stage trial in Turkey.
A COVID-19 vaccine developed by China’s Sinovac Biotech has been 91.25 per cent effective, according to interim data from a late-stage trial in Turkey, a potentially much better result than reported from a separate trial of the vaccine in Brazil.
Key points:
- The Turkish trials began on September 14 and have included more than 7,000 volunteers
- Common adverse effects caused by the vaccine were fever, mild pain and slight fatigue
- 26 of the 29 people who were infected during the trial were given placebos
…
Continue Reading
-
General13 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News17 hours agoNew One Nation branch | Noosa Today
-
Noosa News6 hours agoFederal government to review trade restrictions for Philippine banana imports
-
General10 hours agoBrewer stages beer boycott over Kangaroo Island ferry’s ‘ridiculous’ fares